New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review
Background: Liver diseases post-COVID-19 vaccination is extremely rare but can occur. A growing body of evidence has indicated that portal vein thrombosis, autoimmune hepatitis, raised liver enzymes and liver injuries, etc., may be potential consequence of COVID-19 vaccines. Objectives: To descri...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Published: |
BMC
2022
|
Subjects: | |
Online Access: | http://eprints.sunway.edu.my/3056/ https://doi.org/10.1186/s12876-022-02507-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.sunway.eprints.3056 |
---|---|
record_format |
eprints |
spelling |
my.sunway.eprints.30562024-08-12T00:27:40Z http://eprints.sunway.edu.my/3056/ New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review Alhumaid, Saad Al Mutair, Abbas Rabaan, Ali A AlShakhs, Fatemah M Choudhary, Om Prakash Yong, Shin Jie * Nainu, Firzan Khan, Amjad Muhammad, Javed Alhelal, Fadil Al Khamees, Mohammed Hussain Alsouaib, Hussian Ahmed Al Majhad, Ahmed Salman Al-Tarfi, Hassan Redha ALyasin, Ali Hussain Alatiyyah, Yaqoub Yousef Alsultan, Ali Ahmed Alessa, Mohammed Essa Alessa, Mustafa Essa Alissa, Mohammed Ahmed Alsayegh, Emad Hassan Alshakhs, Hassan N Al Samaeel, Haidar Abdullah AlShayeb, Rugayah Ahmed Alnami, Dalal Ahmed Alhassan, Hussain Ali Alabdullah, Abdulaziz Abdullah Alhmed, Ayat Hussain AlDera, Faisal Hussain Hajissa, Khalid Al-Tawfiq, Jaffar A Al-Omari, Awad QP Physiology QR Microbiology RC Internal medicine Background: Liver diseases post-COVID-19 vaccination is extremely rare but can occur. A growing body of evidence has indicated that portal vein thrombosis, autoimmune hepatitis, raised liver enzymes and liver injuries, etc., may be potential consequence of COVID-19 vaccines. Objectives: To describe the results of a systematic review for new-onset and relapsed liver disease following COVID-19 vaccination. Methods: For this systematic review, we searched Proquest, Medline, Embase, PubMed, CINAHL, Wiley online library, Scopus and Nature through the Preferred Reporting Items for Systematic Reviews and Meta Analyses PRISMA guideline for studies on the incidence of new onset or relapsed liver diseases post-COVID-19 vaccination, published from December 1, 2020 to July 31, 2022, with English language restriction. Results: Two hundred seventy-five cases from one hundred and eighteen articles were included in the qualitative synthesis of this systematic review. Autoimmune hepatitis (138 cases) was the most frequent pathology observed post-COVID-19 vaccination, followed by portal vein thrombosis (52 cases), raised liver enzymes (26 cases) and liver injury (21 cases). Other cases include splanchnic vein thrombosis, acute cellular rejection of the liver, jaundice, hepatomegaly, acute hepatic failure and hepatic porphyria. Mortality was reported in any of the included cases for acute hepatic failure (n = 4, 50%), portal vein thrombosis (n = 25, 48.1%), splanchnic vein thrombosis (n = 6, 42.8%), jaundice (n = 1, 12.5%), raised liver enzymes (n = 2, 7.7%), and autoimmune hepatitis (n = 3, 2.2%). Most patients were easily treated without any serious complications, recovered and did not require long-term hepatic therapy. Conclusion: Reported evidence of liver diseases post-COIVD-19 vaccination should not discourage vaccination against this worldwide pandemic. The number of reported cases is relatively very small in relation to the hundreds of millions of vaccinations that have occurred and the protective benefits offered by COVID-19 vaccination far outweigh the risks. BMC 2022 Article PeerReviewed Alhumaid, Saad and Al Mutair, Abbas and Rabaan, Ali A and AlShakhs, Fatemah M and Choudhary, Om Prakash and Yong, Shin Jie * and Nainu, Firzan and Khan, Amjad and Muhammad, Javed and Alhelal, Fadil and Al Khamees, Mohammed Hussain and Alsouaib, Hussian Ahmed and Al Majhad, Ahmed Salman and Al-Tarfi, Hassan Redha and ALyasin, Ali Hussain and Alatiyyah, Yaqoub Yousef and Alsultan, Ali Ahmed and Alessa, Mohammed Essa and Alessa, Mustafa Essa and Alissa, Mohammed Ahmed and Alsayegh, Emad Hassan and Alshakhs, Hassan N and Al Samaeel, Haidar Abdullah and AlShayeb, Rugayah Ahmed and Alnami, Dalal Ahmed and Alhassan, Hussain Ali and Alabdullah, Abdulaziz Abdullah and Alhmed, Ayat Hussain and AlDera, Faisal Hussain and Hajissa, Khalid and Al-Tawfiq, Jaffar A and Al-Omari, Awad (2022) New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review. BMC Gastroenterology, 22. ISSN 1471-230X https://doi.org/10.1186/s12876-022-02507-3 10.1186/s12876-022-02507-3 |
institution |
Sunway University |
building |
Sunway Campus Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Sunway University |
content_source |
Sunway Institutional Repository |
url_provider |
http://eprints.sunway.edu.my/ |
topic |
QP Physiology QR Microbiology RC Internal medicine |
spellingShingle |
QP Physiology QR Microbiology RC Internal medicine Alhumaid, Saad Al Mutair, Abbas Rabaan, Ali A AlShakhs, Fatemah M Choudhary, Om Prakash Yong, Shin Jie * Nainu, Firzan Khan, Amjad Muhammad, Javed Alhelal, Fadil Al Khamees, Mohammed Hussain Alsouaib, Hussian Ahmed Al Majhad, Ahmed Salman Al-Tarfi, Hassan Redha ALyasin, Ali Hussain Alatiyyah, Yaqoub Yousef Alsultan, Ali Ahmed Alessa, Mohammed Essa Alessa, Mustafa Essa Alissa, Mohammed Ahmed Alsayegh, Emad Hassan Alshakhs, Hassan N Al Samaeel, Haidar Abdullah AlShayeb, Rugayah Ahmed Alnami, Dalal Ahmed Alhassan, Hussain Ali Alabdullah, Abdulaziz Abdullah Alhmed, Ayat Hussain AlDera, Faisal Hussain Hajissa, Khalid Al-Tawfiq, Jaffar A Al-Omari, Awad New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review |
description |
Background: Liver diseases post-COVID-19 vaccination is extremely rare but can occur. A growing body of evidence has indicated that portal vein thrombosis, autoimmune hepatitis, raised liver enzymes and liver injuries, etc., may be potential consequence of COVID-19 vaccines.
Objectives: To describe the results of a systematic review for new-onset and relapsed liver disease following COVID-19 vaccination.
Methods: For this systematic review, we searched Proquest, Medline, Embase, PubMed, CINAHL, Wiley online library, Scopus and Nature through the Preferred Reporting Items for Systematic Reviews and Meta Analyses PRISMA guideline for studies on the incidence of new onset or relapsed liver diseases post-COVID-19 vaccination, published from December 1, 2020 to July 31, 2022, with English language restriction.
Results: Two hundred seventy-five cases from one hundred and eighteen articles were included in the qualitative synthesis of this systematic review. Autoimmune hepatitis (138 cases) was the most frequent pathology observed post-COVID-19 vaccination, followed by portal vein thrombosis (52 cases), raised liver enzymes (26 cases) and liver injury (21 cases). Other cases include splanchnic vein thrombosis, acute cellular rejection of the liver, jaundice, hepatomegaly, acute hepatic failure and hepatic porphyria. Mortality was reported in any of the included cases for acute hepatic failure (n = 4, 50%), portal vein thrombosis (n = 25, 48.1%), splanchnic vein thrombosis (n = 6, 42.8%), jaundice (n = 1, 12.5%), raised liver enzymes (n = 2, 7.7%), and autoimmune hepatitis (n = 3, 2.2%). Most patients were easily treated without any serious complications, recovered and did not require long-term hepatic therapy.
Conclusion: Reported evidence of liver diseases post-COIVD-19 vaccination should not discourage vaccination against this worldwide pandemic. The number of reported cases is relatively very small in relation to the hundreds of millions of vaccinations that have occurred and the protective benefits offered by COVID-19 vaccination far outweigh the risks. |
format |
Article |
author |
Alhumaid, Saad Al Mutair, Abbas Rabaan, Ali A AlShakhs, Fatemah M Choudhary, Om Prakash Yong, Shin Jie * Nainu, Firzan Khan, Amjad Muhammad, Javed Alhelal, Fadil Al Khamees, Mohammed Hussain Alsouaib, Hussian Ahmed Al Majhad, Ahmed Salman Al-Tarfi, Hassan Redha ALyasin, Ali Hussain Alatiyyah, Yaqoub Yousef Alsultan, Ali Ahmed Alessa, Mohammed Essa Alessa, Mustafa Essa Alissa, Mohammed Ahmed Alsayegh, Emad Hassan Alshakhs, Hassan N Al Samaeel, Haidar Abdullah AlShayeb, Rugayah Ahmed Alnami, Dalal Ahmed Alhassan, Hussain Ali Alabdullah, Abdulaziz Abdullah Alhmed, Ayat Hussain AlDera, Faisal Hussain Hajissa, Khalid Al-Tawfiq, Jaffar A Al-Omari, Awad |
author_facet |
Alhumaid, Saad Al Mutair, Abbas Rabaan, Ali A AlShakhs, Fatemah M Choudhary, Om Prakash Yong, Shin Jie * Nainu, Firzan Khan, Amjad Muhammad, Javed Alhelal, Fadil Al Khamees, Mohammed Hussain Alsouaib, Hussian Ahmed Al Majhad, Ahmed Salman Al-Tarfi, Hassan Redha ALyasin, Ali Hussain Alatiyyah, Yaqoub Yousef Alsultan, Ali Ahmed Alessa, Mohammed Essa Alessa, Mustafa Essa Alissa, Mohammed Ahmed Alsayegh, Emad Hassan Alshakhs, Hassan N Al Samaeel, Haidar Abdullah AlShayeb, Rugayah Ahmed Alnami, Dalal Ahmed Alhassan, Hussain Ali Alabdullah, Abdulaziz Abdullah Alhmed, Ayat Hussain AlDera, Faisal Hussain Hajissa, Khalid Al-Tawfiq, Jaffar A Al-Omari, Awad |
author_sort |
Alhumaid, Saad |
title |
New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review |
title_short |
New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review |
title_full |
New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review |
title_fullStr |
New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review |
title_full_unstemmed |
New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review |
title_sort |
new-onset and relapsed liver diseases following covid-19 vaccination: a systematic review |
publisher |
BMC |
publishDate |
2022 |
url |
http://eprints.sunway.edu.my/3056/ https://doi.org/10.1186/s12876-022-02507-3 |
_version_ |
1808975634779602944 |
score |
13.211869 |